These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21054593)

  • 21. Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses.
    Rodbard HW; Green AJ; Fox KM; Grandy S;
    Diabetes Res Clin Pract; 2010 Mar; 87(3):360-5. PubMed ID: 20047768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient co-payment for prescription medicines across Europe--how do we compare?
    Barry M; Tilson L; Ryan M
    Ir Med J; 2004 Mar; 97(3):69-70. PubMed ID: 15164684
    [No Abstract]   [Full Text] [Related]  

  • 23. Prescription abandonment: another path to medication nonadherence.
    Murray MD; Harrison J
    Ann Intern Med; 2010 Nov; 153(10):680-1. PubMed ID: 21079227
    [No Abstract]   [Full Text] [Related]  

  • 24. [The over the counter drugs reform in Israel--two years later].
    Vaknin S; Abadi-Korek I; Marom E; Shemer J; Luxenburg O
    Harefuah; 2011 Jan; 150(1):4-8, 70. PubMed ID: 21449147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between high cost sharing and adverse outcomes: a truism that's tough to prove.
    Choudhry NK
    Am J Manag Care; 2010 Apr; 16(4):287-9. PubMed ID: 20394465
    [No Abstract]   [Full Text] [Related]  

  • 27. Can value-based design in pharmacy save money and cut heart attacks?
    Kirkner RM
    Manag Care; 2011 Feb; 20(2):25-8. PubMed ID: 21428126
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Aust N Z J Public Health; 2009 Jun; 33(3):246-52. PubMed ID: 19630844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends and income related differences in out-of-pocket costs for prescription and over-the-counter medicines in Finland from 1985 to 2006.
    Aaltonen K; Niemelä M; Norris P; Bell JS; Hartikainen S
    Health Policy; 2013 May; 110(2-3):131-40. PubMed ID: 23375359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary non-adherence to prescribed medication in general practice: lack of influence of moderate increases in patient copayment.
    Linnet K; Halldórsson M; Thengilsdóttir G; Einarsson ÓB; Jónsson K; Almarsdóttir AB
    Fam Pract; 2013 Feb; 30(1):69-75. PubMed ID: 22964077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada.
    Contoyannis P; Hurley J; Grootendorst P; Jeon SH; Tamblyn R
    Health Econ; 2005 Sep; 14(9):909-23. PubMed ID: 16127675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consumer habits and interests regarding non-prescription medications in Hungary.
    Major C; Vincze Z
    Fam Pract; 2010 Jun; 27(3):333-8. PubMed ID: 20067976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies Used by Adults Aged 65 and Over to Reduce Their Prescription Drug Costs, 2016-2017.
    Cohen RA; Boersma P
    NCHS Data Brief; 2019 May; (335):1-8. PubMed ID: 31163016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription drug co-payments and cost-related medication underuse.
    Wagner TH; Heisler M; Piette JD
    Health Econ Policy Law; 2008 Jan; 3(Pt 1):51-67. PubMed ID: 18634632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with medicine use among children aged under 12 years--a population survey in Finland.
    Hämeen-Anttila K; Lindell-Osuagwu L; Sepponen K; Vainio K; Halonen P; Ahonen R
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):400-7. PubMed ID: 19937988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
    Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
    Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of herbs use in conjunction with conventional medicines in Jamaica.
    Delgoda R; Younger N; Barrett C; Braithwaite J; Davis D
    Complement Ther Med; 2010 Feb; 18(1):13-20. PubMed ID: 20178874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of non-prescription medicines: knowledge and attitudes of Italian pharmacy customers.
    Cuzzolin L; Benoni G
    Pharm World Sci; 2010 Feb; 32(1):97-102. PubMed ID: 19921545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.
    McRae I; van Gool K; Hall J; Yen L
    Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.